Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis
Clinical trial NCT02607774 · COMPLETED
Trial details
- NCT number
- NCT02607774
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2016-12-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.